519 results
Tricuspid valve disease: diagnosis and treatment selection
22 Nov 2021 – From PCR London Valves 2021
Presented during PCR London Valves 2021, view the case of an 85-year-old patient with hypertension, diabetes, and dyslipidemia, who has permanent atrial fibrillation and renal failure, but no left-sided valvular heart disease and follow the debates around which treatments to adopt!
Transcatheter tricuspid valve interventions: optimal technique and procedural refinement
22 Nov 2021 – From PCR London Valves 2021
With this session from PCR London Valves 2021, learn more about a procedure that is becoming increasingly popular and reproducible: the transcatheter tricuspid valve intervention. Pre-procedural planning, successful management of major complications, and requirements for implementing a program at your center are key topics.
Transcatheter tricuspid valve interventions: prevention of complications and their management
22 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 if you want to find out more about the complications you may encounter during transcatheter tricuspid valve procedures, learn more about how to schedule and prepare for these interventions to avoid complications, and get more tips and tricks...
Right-side THV implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to learn more about tricuspid valve-in-ring for severe symptomatic tricuspid regurgitation, to consider the transcatheter heart valve for isolated tricuspid regurgitation, and to see an unresolved complication in transcatheter tricuspid ViV, among others.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
A heart-team discussion for tricuspid valve intervention
21 Nov 2021 – From PCR London Valves 2021
Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
